Evidence map›Paper›PMID 20822374›Full record

ArticleScandinavian journal of primary health care2010

Who receives anticoagulant treatment with warfarin and why? A population-based study in Finland.

Irma Virjo, Kari Mäkelä, Juhani Aho, Pentti Kalliola, Harri Kurunmäki, Leena Uusitalo, Markku Valli, Suvi Ylinen

Abstract readComparative Study
In one paragraph

Article in Scandinavian journal of primary health care, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Building a primary care research network - lessons to learn.Scandinavian journal of primary health care · 2017
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Irma VirjoDepartment of General Practice, University of Tampere, Hospital District of South Ostrobothnia, Finland. Irma.virjo@uta.fi
Kari Mäkelä
Juhani Aho
Pentti Kalliola
Harri Kurunmäki
Leena Uusitalo
Markku Valli
Suvi Ylinen

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo ascertain the age and gender distribution of patients receiving anticoagulant (AC) treatment with warfarin, and to establish the prevalence of AC treatment and its indications among the Finnish population.

designA cross-sectional study in which the patients were identified from the patient records of health centres.

settingPrimary health care in the Hospital District of South Ostrobothnia in Finland. PATIENTS: Those inhabitants of 15 municipalities in the study area who received AC treatment with warfarin on 1 April 2004. The total number of inhabitants was 132 621 at the end of 2003.

main outcome measuresPatient age and gender distributions, the prevalence of AC treatment in the study area, and indications for AC treatment.

resultsAltogether 2389 patients were identified, 51.4% of them men. The mean age of the patients was 72.4 years. The prevalence of AC treatment was 1.8%; when age-adjusted to match the Finnish population it was 1.64%. The proportion of men receiving AC treatment was higher than that of women in all age groups. Atrial fibrillation (AF) was the most common main (60.2%) and second (7.2%) indication for AC treatment.

conclusionCompared with Finnish figures 12 years earlier the prevalence of AC treatment has more than doubled, and the proportion of AF among indications has increased from 47% to 67%. New current care guidelines on AF and the increasing proportion of the elderly among the population are probable explanations.

Indexed as

AdultAgedAged, 80 and overAnticoagulantsAtrial FibrillationCross-Sectional StudiesFamily PracticeFemaleFinlandHumansMaleMiddle AgedPractice Patterns, Physicians'WarfarinAnticoagulantsWarfarin

Identifiers

PMID20822374
PMCPMC3444796

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.